6-substituted anilino purines as rtk inhibitors

Details 6-substituted anilino purines as rtk inhibitors 6-substituted anilino purines as rtk inhibitors

C - Chemistry, Metallurgy

07

D

C07D 473/40 (2006.01) A61K 31/52 (2006.01) A61K 31/522 (2006.01) A61P 9/10 (2006.01) A61P 11/06 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) C07D 473/16 (2006.01) C07D 473/18 (2006.01) C07D 473/34 (2006.01)

Patent

CA 2535620

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with cSRC, Lck, FGFR3, Flt3, TrkB, Bmx, and/or PFGFR.alpha. kinase activity.

L'invention concerne une nouvelle catégorie de composés, des compositions pharmaceutiques contenant ces composés et des méthodes pour utiliser ces composés dans le traitement ou la prévention de maladies ou de troubles associés à l'activité kinase cSRC, Lck, FGFR3, Flt3, TrkB, Bmx et/ou PFGFR.alpha..

Affiliated with

Also associated with

Rating

6-substituted anilino purines as rtk inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-substituted anilino purines as rtk inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted anilino purines as rtk inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1884240